<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Neuropathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin. Neuropathol</journal-id>
      <journal-id journal-id-type="publisher-id">Dustri</journal-id>
      <journal-title-group>
        <journal-title>Clinical Neuropathology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0722-5091</issn>
      <publisher>
        <publisher-name>Dustri-Verlag Dr. Karl Feistle</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26709713</article-id>
      <article-id pub-id-type="pmc">4806405</article-id>
      <article-id pub-id-type="doi">10.5414/NP300902</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
        <subj-group>
          <subject>Neuropathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spinal muscular atrophy with respiratory distress type 1 (SMARD1) </article-title>
        <subtitle>Report of a Spanish case with extended clinicopathological follow-up</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>San Millan</surname>
            <given-names>Beatriz</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandez</surname>
            <given-names>Jose M.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Navarro</surname>
            <given-names>Carmen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reparaz</surname>
            <given-names>Alfredo</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teijeira</surname>
            <given-names>Susana</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Pathology,</aff>
      <aff id="A2"><label>2</label>Department of Clinical Neurophysiology,</aff>
      <aff id="A3"><label>3</label>Neonatal Intensive Care Unit; Complexo Hospitalario Universitario de Vigo (CHUVI), and</aff>
      <aff id="A4"><label>4</label>Institute of Biomedical Research of Ourense&#xB7;Pontevedra&#xB7;Vigo (IBI), Vigo, Spain</aff>
      <author-notes>
        <corresp id="COR1">Correspondence to Susana Teijeira, PhD Institute of Biomedical Research of Ourense Pontevedra Vigo (IBI), Complexo Hospitalario Universitario de Vigo (CHUVI), Biomedical Research Unit, Hospital &#xC1;lvaro Cunqueiro, 36312 Vigo, Spain <email>susana.teijeira.bautista@sergas.es</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>35</volume>
      <issue>2</issue>
      <fpage>58</fpage>
      <lpage>65</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>9</month>
          <year>2015 </year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Dustri-Verlag Dr. K. Feistle</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
<underline>Background:</underline> Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a clinically and genetically distinct and uncommon variant of SMA that results from irreversible degeneration of &#x3B1;-motor neurons in the anterior horns of the spinal cord and in ganglion cells on the spinal root ganglia. <underline>Aims:</underline> To describe the clinical, electrophysiological, neuropathological, and genetic findings, at different stages from birth to death, of a Spanish child diagnosed with SMARD1. <underline>Patient and methods:</underline> We report the case of a 3-month-old girl with severe respiratory insufficiency and, later, intense hypotonia. Paraclinical tests included biochemistry, chest X-ray, and electrophysiological studies, among others. Muscle and nerve biopsies were performed at 5 and 10 months and studied under light and electron microscopy. Post-mortem examination and genetic investigations were performed. <underline>Results:</underline> Pre- and post-mortem histopathological findings demonstrated the disease progression over time. Muscle biopsy at 5 months of age was normal, however a marked neurogenic atrophy was present in post-mortem samples. Peripheral motor and sensory nerves were severely involved likely due to a primary axonal disorder. Automatic sequencing of <italic>IGHMBP2</italic> revealed a compound heterozygous mutation. <underline>Conclusions:</underline> The diagnosis of SMARD1 should be considered in children with early respiratory insufficiency or in cases of atypical SMA. Direct sequencing of the <italic>IGHMBP2</italic> gene should be performed. </p>
      </abstract>
      <kwd-group>
        <kwd>spinal muscular atrophy</kwd>
        <kwd>SMARD-diaphragmatic palsy</kwd>
        <kwd>respiratory distress</kwd>
        <kwd>peripheral neuropathy </kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s2">
      <title>Introduction </title>
      <p>Spinal muscular atrophy with respiratory distress type 1 (SMARD1, OMIM #604320), also called diaphragmatic SMA, distal hereditary motor neuropathy type VI, or severe infantile axonal neuropathy with respiratory failure, is a clinically and genetically distinct form of spinal muscular atrophy type 1 (SMA1), first described by Mellins et al. in 1974 [<xref rid="b1" ref-type="bibr">1</xref>]. This is an extremely infrequent disease of autosomal recessive inheritance that results from irreversible degeneration of &#x3B1;-motor neurons in the anterior horns of the spinal cord and ganglion cells in the dorsal root ganglia (DRG). It leads to severe muscular atrophy of phrenic predominance causing early respiratory distress. Distal limb weakness subsequently occurs, with severe generalized hypotonia, areflexia, and progressive peripheral neuropathy. Prognosis is very poor and patients die of respiratory failure at an early age. The <italic>IGHMBP2</italic> gene, responsible for SMARD1, is located on chromosome 11q13, which encodes the immunoglobulin mu-binding protein 2 [<xref rid="b2" ref-type="bibr">2</xref>, <xref rid="b3" ref-type="bibr">3</xref>, <xref rid="b4" ref-type="bibr">4</xref>, <xref rid="b5" ref-type="bibr">5</xref>, <xref rid="b6" ref-type="bibr">6</xref>, <xref rid="b7" ref-type="bibr">7</xref>, <xref rid="b8" ref-type="bibr">8</xref>, <xref rid="b9" ref-type="bibr">9</xref>]. </p>
      <p>Here we describe the clinical, electrophysiological and neuropathological findings, at different stages from birth to death, and the genetic studies of a Spanish child diagnosed with SMARD1 and a mutation in <italic>IGHMBP2</italic> [<xref rid="b4" ref-type="bibr">4</xref>]. Prenatal diagnosis was performed in a second pregnancy of the mother by chorionic villous biopsy at 11 weeks&#x2019; gestation. To our knowledge, this is one of the few cases with sequential examinations during life and post-mortem studies. </p>
      <p>SMARD1 should be considered as a differential diagnosis in every newborn with respiratory distress and diaphragmatic paralysis, even prior to muscle weakness onset. </p>
    </sec>
    <sec id="s3">
      <title>Case report </title>
      <p>A 3-month-old girl was admitted to the hospital with respiratory difficulty, tachypnea and forced respiration with retractions, which had been noticed in an ordinary pediatric control. She was the first child of unrelated, young, and healthy parents without familial history of neuromuscular disorders or sudden infant death syndrome. The baby had been born by caesarean section at 34 weeks gestation due to intrauterine growth retardation (IUGR), decreased fetal movements, and abruptio placentae diagnoses. She weighed 1,550&#xA0;g at birth (&lt;&#xA0;10<sup>th</sup> percentile), with an Apgar score of 8/10, and presented neonatal respiratory distress immediately after birth, requiring mechanical ventilation and pulmonary surfactants for 3 days. </p>
      <p>On admission at 3 months, pulmonary auscultation revealed severe bilateral hypoventilation with crepitus. Chest X-ray suggested bronchiolitis and she received corticoids and oxygen without improvement. The disease progressed to severe respiratory insufficiency, requiring mechanical ventilation. Repeated efforts to wean her from ventilator resulted unsuccessful. </p>
      <p>Limb weakness with distal to proximal progression appeared shortly after the onset of respiratory insufficiency, with marked generalized hypotonia, areflexia, bilateral equinovarus foot deformities, and Achilles contractures. Tongue fasciculations were absent. </p>
      <p>Serologic and biochemical parameters, including creatinine kinase levels and cerebrospinal fluid analyses were normal. Results from other tests performed for infective and metabolic conditions were unrevealing. </p>
      <p>On electrophysiological examination, sensory potentials were abolished in the lower limbs and fingers. The only recordable potential was that of the median nerve (amplitude 2.6&#xA0;&#xB5;V, SCV 21 m/s) (<xref ref-type="table" rid="Table1">Table 1</xref>). Concentric needle examination revealed severe partial denervation in all examined muscles of the upper and lower limbs. Complete denervation of the left hemidiaphragm was demonstrated. </p>
      <p>Electroencephalogram, brain magnetic resonance imaging (MRI), and cardiologic studies did not show abnormalities. Genetic analysis for Survival Motor Neuron (<italic>SMN1</italic>) gene was negative. Electron microscopy of skin and biochemical assays in cultured fibroblasts ruled out metachromatic and globoid cell leukodystrophies. </p>
      <p>Muscle and nerve biopsies were performed at 5 and 10 months of age. At 5 months muscle biopsy was nearly normal. However, sural nerve biopsy at that age demonstrated significant decrease in myelinated fiber density (<xref ref-type="fig" rid="Figure1">Figure 1</xref>A) with no evidence of inflammation. At electron microscopy examination, no onion bulbs or axonal cluster formation were present. Microtubules and neurofilaments were normal. Giant axons, metachromasia, or lysosomal storage were absent (<xref ref-type="fig" rid="Figure1">Figure 1</xref>B). </p>
      <p>Electrophysiological examinations at 11 months of age demonstrated complete denervation in the most distal muscles (tibialis anterior, gastrocnemius, and foot muscles) and severely reduced interference pattern in the most proximal ones (vastus lateralis, deltoid, and facial muscles) (<xref ref-type="table" rid="Table1">Table 1</xref>). At that age, marked atrophy of both type I and type II fibers was found in muscle biopsy (<xref ref-type="fig" rid="Figure1">Figure&#xA0;1</xref>C) with fibers showing prominent nuclei and increased oxidative activity, clearly demonstrative of a neurogenic process (<xref ref-type="fig" rid="Figure1">Figure 1</xref>D) showing features of immature fetal phenotype (<xref ref-type="fig" rid="Figure2">Figure 2</xref>). </p>
      <p>Despite therapeutic efforts, the condition of the child rapidly deteriorated, resulting in complete paralysis of limbs and trunk. In the end stage of the disease, tracheostomy and gastrostomy were required, and the baby developed recurrent pulmonary, urinary, and systemic infections. Autonomic manifestations subsequently occurred, including neurogenic bladder and cardiac arrhythmia. The child died of respiratory failure at 23 months of age. Permission to perform a necropsy was obtained. </p>
      <p>Post-mortem examination revealed bilateral pneumonic consolidation and pleural effusion. The spinal cord showed a reduced anterior spinal root diameter and prominent loss of motor neurons in the anterior horns (<xref ref-type="fig" rid="Figure3">Figure 3</xref>A), extending from the cervical to the lumbar region. The remaining motor neurons displayed chromatolysis and pyknosis (<xref ref-type="fig" rid="Figure3">Figure 3</xref>B). In DRG, significant neuronal loss was observed (<xref ref-type="fig" rid="Figure3">Figure 3</xref>C), better depicted with S100 immunohistochemistry. The overall size of nerve cells was small with abundant clusters of satellite cells&#x2019; nuclei (Nageotte nodules). No abnormalities were present in the brain and midbrain motor nuclei. </p>
      <p>Severe axonal depletion was found in sural (<xref ref-type="fig" rid="Figure3">Figure 3</xref>D) and sciatic (<xref ref-type="fig" rid="Figure3">Figure 3</xref>E) nerve samples, with less than 50&#xA0;&#x2013;&#xA0;60% of preserved fibers and prominent endoneurial fibrosis. Fibers showed thin myelin sheaths without signs of active demyelination or remyelination. Non-myelinated fibers were morphologically normal and basal lamina did not show abnormalities. Onion bulbs, axonal sprouts, or inflammatory infiltrates were absent. </p>
      <p>Muscle samples from the limbs, diaphragm, and intercostal muscles showed large groups of atrophic fibers with frequent nuclear clumps, massive adipose infiltration, and fibrosis, particularly in the diaphragm (<xref ref-type="fig" rid="Figure3">Figure 3</xref>F). </p>
      <p>Further genetic studies were performed. Automatic sequencing of all 15 exons and flanking regions of <italic>IGHMBP2</italic> on 11q13-q21 revealed a compound heterozygous mutation R147X/C496X ([<xref rid="b4" ref-type="bibr">4</xref>], case no. 15). These mutations were demonstrated in the father and the mother respectively. </p>
      <p>Some years later, the mother became pregnant and underwent prenatal diagnostic tests in a chorionic villi biopsy at 11 weeks&#x2019; gestation, with her written informed consent. Prenatal molecular analysis in DNA extracted from chorionic villi samples proved the second fetus to be single heterozygote, harboring the paternal mutation. The pregnancy was continued, and a healthy girl was born at term and remains unaffected at 5 years of age. </p>
    </sec>
    <sec id="s4">
      <title>Discussion </title>
      <p>SMARD1 is characterized by degeneration of anterior horn spinal motor neurons, leading to rapidly progressive neurogenic muscular atrophy of limbs and diaphragm [<xref rid="b3" ref-type="bibr">3</xref>]. Neurons on the DRG also degenerate, leading to an axonal neuronopathy, whereas involvement of the cranial nerves has only been reported in advanced cases [<xref rid="b4" ref-type="bibr">4</xref>]. Phenotype variability has been described even in siblings with identical mutations [<xref rid="b10" ref-type="bibr">10</xref>], and prenatal manifestations are not uncommon including IUGR, prematurity, and decreased fetal movements [<xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>]. An exhaustive clinicopathological review of 125 SMARD1 cases has been recently reported [<xref rid="b13" ref-type="bibr">13</xref>]. Our data, compared to those previously reported, are shown on <xref ref-type="table" rid="Table2">Table 2</xref>. </p>
      <p>Some cases show early feeding difficulties or weak cry, but respiratory distress is the most common presenting feature. SMARD1 phenotype may be broader than initially considered [<xref rid="b2" ref-type="bibr">2</xref>, <xref rid="b10" ref-type="bibr">10</xref>, <xref rid="b13" ref-type="bibr">13</xref>], and few cases with milder phenotype and no evidence of diaphragmatic involvement until 4 years of age have been reported [<xref rid="b2" ref-type="bibr">2</xref>]. Respiratory distress resulting from irreversible phrenic denervation requires mechanical ventilation from early stages until death, which usually occurs in the first years of life. Unusual prolonged survival has been reported in some patients upon mechanical ventilation (from 4.5 to 21 years of age) due to exemplary care [<xref rid="b14" ref-type="bibr">14</xref>, <xref rid="b15" ref-type="bibr">15</xref>]. </p>
      <p>Phrenic paralysis can be demonstrated on chest X-ray as diaphragmatic eventration and by electrophysiological studies, as in the present case. Plication of the diaphragm has been performed in several patients without success [<xref rid="b16" ref-type="bibr">16</xref>], and to date there is no effective drug therapy. At present, stem cell transplantation and gene therapy represent a potentially useful treatment strategy to ameliorate the SMARD1 phenotype [<xref rid="b17" ref-type="bibr">17</xref>, <xref rid="b18" ref-type="bibr">18</xref>]. </p>
      <p>The child herein reported suffered her first respiratory distress episode early after birth, requiring mechanical ventilation. After the second episode, at 3 months of age, she remained ventilator-dependent until death at age 23 months. Diaphragmatic paralysis was demonstrated on the left hemidiaphragm by electrophysiological examination. Curiously, SMARD1 patients reported so far exhibited predominant right phrenic involvement, probably resulting from the pressure effect caused by the liver [<xref rid="b13" ref-type="bibr">13</xref>, <xref rid="b16" ref-type="bibr">16</xref>]. </p>
      <p>Distal limb weakness, progressive generalized hypotonia, and foot deformities appeared after respiratory insufficiency. Quadriplegia, finger contractures, and fatty pads on the proximal phalanges resulting from adipose tissue infiltration, subsequently developed [<xref rid="b4" ref-type="bibr">4</xref>, <xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b19" ref-type="bibr">19</xref>]. </p>
      <p>In addition to motor neuron involvement, neurons in the DRG are also involved in SMARD1, causing axonal sensory neuronopathy with distal to proximal progression. Significant neuronal loss and residual nodules of Nageotte at sites of destroyed neurons were clearly demonstrated in DRG at post-mortem examination. </p>
      <p>Corresponding to the clinical features, progressive loss of response for motor and sensory conduction velocities was observed, leading to an absent response after maximum stimulation in the end stage of the disease. </p>
      <p>Autonomic nervous system involvement is well documented in SMARD1, including excessive sweating, constipation, cardiac rhythm abnormalities, or sphincter control dysregulation [<xref rid="b12" ref-type="bibr">12</xref>, <xref rid="b20" ref-type="bibr">20</xref>]. In the present case, cardiac arrhythmia and neurogenic bladder appeared late in the course of the disease. </p>
      <p>Pre- and post-mortem histopathological findings in nerves and muscles demonstrated the progression over time of SMARD1. Muscle biopsy at 5&#xA0;months of age was considered normal, in contrast to significant loss of myelinated fibers observed in sural biopsy. A considerable degree of muscle involvement was noted at 10&#xA0;months, with definite signs of neurogenic atrophy without signs of reinnervation. </p>
      <p>A marked progression of muscle damage was present in post-mortem samples, with the most severe damage in the diaphragm. </p>
      <p>Peripheral motor and sensory nerves were severely involved and the histopathological picture was most likely due to a primary axonal disorder, as there were no signs of demyelination/remyelination or onion bulb formation and the myelin in the remaining fibers was of normal thickness. There was no evidence of hypomyelination, thus excluding the diagnosis of congenital amyelinating or demyelinating neuropathy [<xref rid="b21" ref-type="bibr">21</xref>, <xref rid="b22" ref-type="bibr">22</xref>, <xref rid="b23" ref-type="bibr">23</xref>]. The spinal cord exhibited extensive loss of motor neurons in the anterior horns and DRG showed a marked reduction of ganglionic cells. </p>
      <p>Differential diagnosis of SMARD1 includes disorders displaying acute, early respiratory insufficiency and other causes of floppy infant syndrome. Some children were reported to have died from acute respiratory infection or sudden infant death syndrome [<xref rid="b7" ref-type="bibr">7</xref>, <xref rid="b24" ref-type="bibr">24</xref>]. The main differential diagnosis should be established with SMARD2, a rare X-linked disorder with SMARD phenotype and mutations in <italic>LAS1L</italic> (ORPHA404521) [<xref rid="b25" ref-type="bibr">25</xref>]. Other possible diagnoses include SMA1 (Werdnig-Hoffmann disease). In contrast to SMARD1, proximal muscle weakness is the presenting sign of SMA1, and the respiration is compromised due to intercostal muscle involvement, as the disease progresses, causing paradoxical breathing and a bell-shaped thorax deformity. SMARD1 early involves phrenic muscle, without causing thoracic deformities. Peripheral sensory neuropathy, a hallmark of SMARD1, is not typically present in SMA1, although isolated cases have been reported [<xref rid="b26" ref-type="bibr">26</xref>]. Both SMA and SMARD1 children have normal intelligence and remain alert and attentive. </p>
      <p>Other causes of floppy infant syndrome must be considered, including glycogenosis type II (Pompe disease), or congenital myopathies (CM) with usually distinctive histopathological features. Congenital myotonic dystrophy type 1 presents with pronounced myopathic typical facies, arthrogryposis, and familial history [<xref rid="b27" ref-type="bibr">27</xref>]. Neonatal myasthenia gravis and congenital forms of myasthenic syndrome must be excluded, based on electromyographic findings and familial history. The lesional topography and fatal course of the disease in this patient were not suggestive of other disorders such as arthrogryposis multiplex congenita. </p>
      <p>IGHMBP2 is a ubiquitous ribosome-associated enzyme, that functions as a 5&#x2019;-3&#x2019; RNA/DNA helicase [<xref rid="b28" ref-type="bibr">28</xref>]. The cellular pathomechanisms that result from <italic>IGHMBP2</italic> gene mutations are not well understood. Pathogenesis of motor neuron diseases as a group could be related with RNA metabolism [<xref rid="b29" ref-type="bibr">29</xref>]. <italic>IGHMBP2</italic> and <italic>LAS1L</italic>, both resulting in SMARD phenotypes, have roles in ribosomal biogenesis via processing of the 45S pre-rRNA [<xref rid="b25" ref-type="bibr">25</xref>]. However, a direct interaction between them has not been demonstrated [<xref rid="b25" ref-type="bibr">25</xref>]. </p>
      <p>In conclusion, we describe the neuropathological and electrophysiological findings of a Spanish patient with SMARD1, one of the more detailed cases with follow-up studies and post-mortem examination. The diagnosis of SMARD1, a more frequent disorder than suspected, should be considered in children with early respiratory insufficiency or in cases of atypical spinal muscular atrophy, even in the absence of overt diaphragmatic weakness [<xref rid="b10" ref-type="bibr">10</xref>]. SMARD1 diagnosis is of particular importance as it allows accurate genetic counselling and assists in the decision-making process for the initiation of mechanical ventilation of an affected infant [<xref rid="b30" ref-type="bibr">30</xref>]. Direct sequencing of the <italic>IGHMBP2</italic> gene should be performed if clinical and neuropathological features are compatible and <italic>SMN1</italic> mutation studies have been negative. Cases with normal <italic>IGHMBP2</italic> study should be screened for <italic>LAS1L</italic> mutations. Genetic counselling and prenatal diagnosis should be offered to all families with a familial history of SMARD1 in order to discuss the options and risks. </p>
    </sec>
    <sec id="s5">
      <title>Acknowledgment </title>
      <p>We thank Tania Vazquez-Santos, Cristina Vazquez-Santos, and Soraya Barrera for technical assistance. This work was supported in part by Grants from the &#x201C;Instituto de Salud Carlos III, ISCIII&#x201D; (PI10/02628 and RD09/0076/00011); Xunta de Galicia (REGENPSI&#x2013;2009/013) and by European Union funded projects Spain-RDR &#x201C;Spanish Rare Disease Registries Research Network&#x201D; (IRDiRC) and BIOCAPS (FP7/REGPOT-2012-2013.1, agreement n&#xBA; 316265). </p>
    </sec>
    <sec id="s6">
      <title>Conflict of interests </title>
      <p>The authors declare no conflict of interest. </p>
      <p>
<table-wrap id="Table1" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Motor neurography performed in several nerves at 4, 11, and 16 months of age.</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="1" colspan="1">Nerve</th><th rowspan="1" colspan="1">Distal latency <break/>(ms)</th><th rowspan="1" colspan="1">Amplitude <break/>(&#xB5;V)</th><th rowspan="1" colspan="1">MCV <break/>(m/s)</th><th rowspan="1" colspan="1">F-Lat</th></tr></thead><tbody><tr><td colspan="5" rowspan="1">At 4 months of age</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Median</td><td rowspan="1" colspan="1">3.0</td><td rowspan="1" colspan="1">2.6</td><td rowspan="1" colspan="1">19.0</td><td rowspan="1" colspan="1">18.0</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Right peroneal</td><td rowspan="1" colspan="1">5.2</td><td rowspan="1" colspan="1">0.3</td><td rowspan="1" colspan="1">14.0</td><td rowspan="1" colspan="1">Absent</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Left tibial</td><td rowspan="1" colspan="1">5.0</td><td rowspan="1" colspan="1">1.2</td><td rowspan="1" colspan="1">13.0</td><td rowspan="1" colspan="1">45.7</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Right phrenic</td><td rowspan="1" colspan="1">5.5</td><td rowspan="1" colspan="1">0.1</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Left phrenic</td><td rowspan="1" colspan="1">5.4</td><td rowspan="1" colspan="1">0.1</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">ND</td></tr><tr><td colspan="5" rowspan="1">At 11 months of age</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Median</td><td rowspan="1" colspan="1">3.4</td><td rowspan="1" colspan="1">0.6</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">18.8</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Peroneal</td><td rowspan="1" colspan="1">4.3</td><td rowspan="1" colspan="1">0.2</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Tibialis</td><td rowspan="1" colspan="1">5.6</td><td rowspan="1" colspan="1">0.3</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Facial</td><td rowspan="1" colspan="1">4.3</td><td rowspan="1" colspan="1">0.3</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Axilaris</td><td rowspan="1" colspan="1">2.7</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">ND</td></tr><tr><td colspan="5" rowspan="1">At 16 months of age</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Median</td><td rowspan="1" colspan="1">4.9</td><td rowspan="1" colspan="1">0.1</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Facial</td><td rowspan="1" colspan="1">3.9</td><td rowspan="1" colspan="1">0.8</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">&#xA0;&#xA0;Axilaris</td><td rowspan="1" colspan="1">4.8</td><td rowspan="1" colspan="1">1.2</td><td rowspan="1" colspan="1">ND</td><td rowspan="1" colspan="1">ND</td></tr></tbody></table><table-wrap-foot><p>MCV = motor conduction velocity; F-Lat = F-wave latency; ND = not done.</p></table-wrap-foot></table-wrap>
</p>
      <fig id="Figure1" orientation="portrait" position="float">
        <label>Figure 1.</label>
        <caption>
          <title>A: Semithin section of sural nerve biopsy at 5 months of age showing marked reduction of myelinated fiber density and endoneurial fibrosis, without onion bulbs, axonal sprouting, or inflammatory infiltrates. (Toluidine blue 200&#xD7;). B: Demyelinated axons and Schwann cells arranged into bands of B&#xFC;ngner under electron microscopy examination of the sural nerve sample at 5 months. C: Muscle biopsy at 10 months of age (H&#xA0;&amp;&#xA0;E 200&#xD7;). Note marked peri and endomysial fibrosis and fatty infiltration with groups of small fibers and scattered hypertrophic fibers. D: NADH staining showing atrophic fibers with increased oxidative activity (NADH 200x).</title>
        </caption>
        <graphic xlink:href="clinneuropathol-35-058-01"/>
      </fig>
      <fig id="Figure2" orientation="portrait" position="float">
        <label>Figure 2.</label>
        <caption>
          <title>Immunohistochemical expression of developmental (dMHC), slow (sMHC), and fast (fMHC) myosin heavy chains in muscle biopsy at 10 months of age showing features of immature fetal phenotype. A: Developmental myosin predominates in atrophic and a few hypertrophic fibers (dMHC 200&#xD7;). B: Slow HC myosin: hypertrophic fibers are characterized by their predominant expression; atrophic fibers also express slow HC. C: Fast MHC: atrophic fibers.</title>
        </caption>
        <graphic xlink:href="clinneuropathol-35-058-02"/>
      </fig>
      <fig id="Figure3" orientation="portrait" position="float">
        <label>Figure 3.</label>
        <caption>
          <title>Post-mortem findings: A: Anterior horn of the spinal cord showing atrophy and significant reduction of motor neurons (H&#xA0;&amp;&#xA0;E 200&#xD7;). B: The remaining neurons presented chromatolysis and pyknosis (H&#xA0;&amp;&#xA0;E 400&#xD7;). C: Dorsal root ganglia with marked neuronal loss and abundant clusters of satellite cells&#x2019; nuclei (Nageotte nodules) (H&#xA0;&amp;&#xA0;E 200&#xD7;). D; E: Semithin sections. Remarkable nerve damage in sural and sciatic nerves, respectively, consisting of massive loss of myelinated fibers without signs of axonal regeneration or remyelination (Toluidine blue 100&#xD7;). F: Severe fiber atrophy, fibrosis, and infiltration of diaphragmatic muscle sample (H&#xA0;&amp;&#xA0;E 200&#xD7;). </title>
        </caption>
        <graphic xlink:href="clinneuropathol-35-058-03"/>
      </fig>
      <p>
<table-wrap id="Table2" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Clinical and histopathological findings.</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Porro et al., 2014 [<xref rid="b13" ref-type="bibr">13</xref>] <break/>(Review 1974&#xA0;&#x2013;&#xA0;2014)</th><th rowspan="1" colspan="1">San Mill&#xE1;n et al</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Cases</td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">Case report</td></tr><tr><td rowspan="1" colspan="1">Onset of respiratory symptoms</td><td rowspan="1" colspan="1">From birth &#x2013; 3.5 years</td><td rowspan="1" colspan="1">First episode: at birth <break/>Second episode: 3 months</td></tr><tr><td rowspan="1" colspan="1">Age of death</td><td rowspan="1" colspan="1">1 hour &#x2013; 5 years</td><td rowspan="1" colspan="1">23 months</td></tr><tr><td rowspan="1" colspan="1">Prenatal symptoms</td><td rowspan="1" colspan="1">None <break/>IUGR, Prematurity <break/>Low birth weight <break/>Oligohydramnios</td><td rowspan="1" colspan="1">IUGR <break/>Decreased fetal movements <break/>Abruptio placentae <break/>Low birth weight</td></tr><tr><td rowspan="1" colspan="1">Diaphragmatic involvement</td><td rowspan="1" colspan="1">Diaphragmatic paralysis: <break/>&#x2022; Eventration in imaging <break/>&#x2022; Right hemidiaphragm involvement <break/>&#x2022; Respiratory weakness and recurrent pulmonary infections</td><td rowspan="1" colspan="1">Diaphragmatic paralysis: <break/>&#x2022; Eventration on chest X-Ray and electromyopgraphy <break/>&#x2022; Left hemidiaphragm involvement <break/>&#x2022; Bronchiolitis <break/>&#x2022; Death from pneumonia</td></tr><tr><td rowspan="1" colspan="1">Neuromuscular features</td><td rowspan="1" colspan="1">Hypotonia, areflexia, lingual fasciculations, weak cry, proximal and distal limb weakness, ankle and knee joint contractures, pes equinus, foot deformities, axonal sensory-motor neuropathy</td><td rowspan="1" colspan="1">Hypotonia, areflexia, weak cry, limb weakness with predominant distal involvement, pes equinovarus, Achilles and finger contractures, axonal sensory-motor neuropathy</td></tr><tr><td rowspan="1" colspan="1">CNS sensorial and autonomic</td><td rowspan="1" colspan="1">Cognitive dysfunction, language dysfunction, hypertension, urinary retention, feeding difficulties, dysphagia, slow peristalsis, arrhythmia, sweating, seizures, cardiovascular collapse</td><td rowspan="1" colspan="1">Neurogenic bladder <break/>Cardiac arrhythmia</td></tr><tr><td rowspan="1" colspan="1">Neuropathology</td><td rowspan="1" colspan="1">Spinal cord: <break/>&#x2022; Degeneration and loss of anterior horn cells, atrophy of the nerve roots <break/>Skeletal muscle: <break/>&#x2022; Neurogenic atrophy (limbs and diaphragm) <break/>Peripheral nerves: <break/>&#x2022; Axonal degeneration and atrophy</td><td rowspan="1" colspan="1">Spinal cord: <break/>&#x2022; Degeneration and loss of anterior horn cells, atrophy of nerve roots <break/>&#x2022; Neuronal loss in dorsal root ganglia, Nageotte nodules <break/>Skeletal muscles (limbs, diaphragm, intercostal): <break/>&#x2022; Severe neurogenic atrophy, particularly in the diaphragm <break/>Peripheral nerves: <break/>&#x2022; Severe axonal depletion in sural and sciatic nerves, endoneurial fibrosis, thin myelin sheaths</td></tr></tbody></table></table-wrap>
</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Mellins</surname><given-names>RB</given-names></name>
<name><surname>Hays</surname><given-names>AP</given-names></name>
<name><surname>Gold</surname><given-names>AP</given-names></name>
<name><surname>Berdon</surname><given-names>WE</given-names></name>
<name><surname>Bowdler</surname><given-names>JD</given-names></name>
<article-title>Respiratory distress as the initial manifestation of Werdnig-Hoffmann disease.</article-title>
<source>Pediatrics</source>.
<year>1974</year>;
<volume>53</volume>:
<fpage>33</fpage>&#x2013;<lpage>40</lpage>.
<pub-id pub-id-type="pmid">4809192</pub-id></mixed-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Grohmann</surname><given-names>K</given-names></name>
<name><surname>Wienker</surname><given-names>TF</given-names></name>
<name><surname>Saar</surname><given-names>K</given-names></name>
<name><surname>Rudnik-Sch&#xF6;neborn</surname><given-names>S</given-names></name>
<name><surname>Stoltenburg-Didinger</surname><given-names>G</given-names></name>
<name><surname>Rossi</surname><given-names>R</given-names></name>
<name><surname>Novelli</surname><given-names>G</given-names></name>
<name><surname>N&#xFC;rnberg</surname><given-names>G</given-names></name>
<name><surname>Pfeufer</surname><given-names>A</given-names></name>
<name><surname>Wirth</surname><given-names>B</given-names></name>
<name><surname>Reis</surname><given-names>A</given-names></name>
<name><surname>Zerres</surname><given-names>K</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<article-title>Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21.</article-title>
<source>Am J Hum Genet</source>.
<year>1999</year>;
<volume>65</volume>:
<fpage>1459</fpage>&#x2013;<lpage>1462</lpage>.
<pub-id pub-id-type="pmid">10521314</pub-id></mixed-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Grohmann</surname><given-names>K</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>Diers</surname><given-names>A</given-names></name>
<name><surname>Hoffmann</surname><given-names>K</given-names></name>
<name><surname>Lucke</surname><given-names>B</given-names></name>
<name><surname>Adams</surname><given-names>C</given-names></name>
<name><surname>Bertini</surname><given-names>E</given-names></name>
<name><surname>Leonhardt-Horti</surname><given-names>H</given-names></name>
<name><surname>Muntoni</surname><given-names>F</given-names></name>
<name><surname>Ouvrier</surname><given-names>R</given-names></name>
<name><surname>Pfeufer</surname><given-names>A</given-names></name>
<name><surname>Rossi</surname><given-names>R</given-names></name>
<name><surname>Van Maldergem</surname><given-names>L</given-names></name>
<name><surname>Wilmshurst</surname><given-names>JM</given-names></name>
<name><surname>Wienker</surname><given-names>TF</given-names></name>
<name><surname>Sendtner</surname><given-names>M</given-names></name>
<name><surname>Rudnik-Sch&#xF6;neborn</surname><given-names>S</given-names></name>
<name><surname>Zerres</surname><given-names>K</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<article-title>Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.</article-title>
<source>Nat Genet</source>.
<year>2001</year>;
<volume>29</volume>:
<fpage>75</fpage>&#x2013;<lpage>77</lpage>.
<pub-id pub-id-type="pmid">11528396</pub-id></mixed-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Grohmann</surname><given-names>K</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<name><surname>Stolz</surname><given-names>P</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>Janetzki</surname><given-names>C</given-names></name>
<name><surname>Bertini</surname><given-names>E</given-names></name>
<name><surname>Bushby</surname><given-names>K</given-names></name>
<name><surname>Muntoni</surname><given-names>F</given-names></name>
<name><surname>Ouvrier</surname><given-names>R</given-names></name>
<name><surname>Van Maldergem</surname><given-names>L</given-names></name>
<name><surname>Goemans</surname><given-names>NM</given-names></name>
<name><surname>Lochm&#xFC;ller</surname><given-names>H</given-names></name>
<name><surname>Eichholz</surname><given-names>S</given-names></name>
<name><surname>Adams</surname><given-names>C</given-names></name>
<name><surname>Bosch</surname><given-names>F</given-names></name>
<name><surname>Grattan-Smith</surname><given-names>P</given-names></name>
<name><surname>Navarro</surname><given-names>C</given-names></name>
<name><surname>Neitzel</surname><given-names>H</given-names></name>
<name><surname>Polster</surname><given-names>T</given-names></name>
<name><surname>Topalo&#x11F;lu</surname><given-names>H</given-names></name>
<article-title>Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).</article-title>
<source>Ann Neurol</source>.
<year>2003</year>;
<volume>54</volume>:
<fpage>719</fpage>&#x2013;<lpage>724</lpage>.
<pub-id pub-id-type="pmid">14681881</pub-id></mixed-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Guenther</surname><given-names>UP</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>Bertini</surname><given-names>E</given-names></name>
<name><surname>D&#x2019;Amico</surname><given-names>A</given-names></name>
<name><surname>Goemans</surname><given-names>N</given-names></name>
<name><surname>Grohmann</surname><given-names>K</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<article-title>Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1.</article-title>
<source>Hum Genet</source>.
<year>2004</year>;
<volume>115</volume>:
<fpage>319</fpage>&#x2013;<lpage>326</lpage>.
<pub-id pub-id-type="pmid">15290238</pub-id></mixed-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Guenther</surname><given-names>UP</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<name><surname>Schlicke</surname><given-names>M</given-names></name>
<name><surname>Dutrannoy</surname><given-names>V</given-names></name>
<name><surname>Volk</surname><given-names>A</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<name><surname>von Au</surname><given-names>K</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<article-title>Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis.</article-title>
<source>Hum Mutat</source>.
<year>2007</year>;
<volume>28</volume>:
<fpage>808</fpage>&#x2013;<lpage>815</lpage>.
<pub-id pub-id-type="pmid">17431882</pub-id></mixed-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Bertini</surname><given-names>E</given-names></name>
<name><surname>Gadisseux</surname><given-names>JL</given-names></name>
<name><surname>Palmieri</surname><given-names>G</given-names></name>
<name><surname>Ricci</surname><given-names>E</given-names></name>
<name><surname>Di Capua</surname><given-names>M</given-names></name>
<name><surname>Ferriere</surname><given-names>G</given-names></name>
<name><surname>Lyon</surname><given-names>G</given-names></name>
<article-title>Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.</article-title>
<source>Am J Med Genet</source>.
<year>1989</year>;
<volume>33</volume>:
<fpage>328</fpage>&#x2013;<lpage>335</lpage>.
<pub-id pub-id-type="pmid">2801766</pub-id></mixed-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Novelli</surname><given-names>G</given-names></name>
<name><surname>Capon</surname><given-names>F</given-names></name>
<name><surname>Tamisari</surname><given-names>L</given-names></name>
<name><surname>Grandi</surname><given-names>E</given-names></name>
<name><surname>Angelini</surname><given-names>C</given-names></name>
<name><surname>Guerrini</surname><given-names>P</given-names></name>
<name><surname>Dallapiccola</surname><given-names>B</given-names></name>
<article-title>Neonatal spinal muscular atrophy with diaphragmatic paralysis is unlinked to 5q11.2-q13.</article-title>
<source>J Med Genet</source>.
<year>1995</year>;
<volume>32</volume>:
<fpage>216</fpage>&#x2013;<lpage>219</lpage>.
<pub-id pub-id-type="pmid">7783173</pub-id></mixed-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Basel-Vanagaite</surname><given-names>L</given-names></name>
<name><surname>Taub</surname><given-names>E</given-names></name>
<name><surname>Drasinover</surname><given-names>V</given-names></name>
<name><surname>Magal</surname><given-names>N</given-names></name>
<name><surname>Brudner</surname><given-names>A</given-names></name>
<name><surname>Zlotogora</surname><given-names>J</given-names></name>
<name><surname>Shohat</surname><given-names>M</given-names></name>
<article-title>Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.</article-title>
<source>Genet Test</source>.
<year>2008</year>;
<volume>12</volume>:
<fpage>53</fpage>&#x2013;<lpage>56</lpage>.
<pub-id pub-id-type="pmid">18298318</pub-id></mixed-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Joseph</surname><given-names>S</given-names></name>
<name><surname>Robb</surname><given-names>SA</given-names></name>
<name><surname>Mohammed</surname><given-names>S</given-names></name>
<name><surname>Lillis</surname><given-names>S</given-names></name>
<name><surname>Simonds</surname><given-names>A</given-names></name>
<name><surname>Manzur</surname><given-names>AY</given-names></name>
<name><surname>Walter</surname><given-names>S</given-names></name>
<name><surname>Wraige</surname><given-names>E</given-names></name>
<article-title>Interfamilial phenotypic heterogeneity in SMARD1.</article-title>
<source>Neuromuscul Disord</source>.
<year>2009</year>;
<volume>19</volume>:
<fpage>193</fpage>&#x2013;<lpage>195</lpage>.
<pub-id pub-id-type="pmid">19157874</pub-id></mixed-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Kaindl</surname><given-names>AM</given-names></name>
<name><surname>Guenther</surname><given-names>UP</given-names></name>
<name><surname>Rudnik-Sch&#xF6;neborn</surname><given-names>S</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<name><surname>Zerres</surname><given-names>K</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<name><surname>von Au</surname><given-names>K</given-names></name>
<article-title>Spinal muscular atrophy with respiratory distress type 1 (SMARD1).</article-title>
<source>J Child Neurol</source>.
<year>2008</year>;
<volume>23</volume>:
<fpage>199</fpage>&#x2013;<lpage>204</lpage>.
<pub-id pub-id-type="pmid">18263757</pub-id></mixed-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Eckart</surname><given-names>M</given-names></name>
<name><surname>Guenther</surname><given-names>UP</given-names></name>
<name><surname>Idkowiak</surname><given-names>J</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<name><surname>Grolle</surname><given-names>B</given-names></name>
<name><surname>Boffi</surname><given-names>P</given-names></name>
<name><surname>Van Maldergem</surname><given-names>L</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>von Au</surname><given-names>K</given-names></name>
<article-title>The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).</article-title>
<source>Pediatrics</source>.
<year>2012</year>;
<volume>129</volume>:
<fpage>e148</fpage>&#x2013;<lpage>e156</lpage>.
<pub-id pub-id-type="pmid">22157136</pub-id></mixed-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Porro</surname><given-names>F</given-names></name>
<name><surname>Rinchetti</surname><given-names>P</given-names></name>
<name><surname>Magri</surname><given-names>F</given-names></name>
<name><surname>Riboldi</surname><given-names>G</given-names></name>
<name><surname>Nizzardo</surname><given-names>M</given-names></name>
<name><surname>Simone</surname><given-names>C</given-names></name>
<name><surname>Zanetta</surname><given-names>C</given-names></name>
<name><surname>Faravelli</surname><given-names>I</given-names></name>
<name><surname>Corti</surname><given-names>S</given-names></name>
<article-title>The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.</article-title>
<source>J Neurol Sci</source>.
<year>2014</year>;
<volume>346</volume>:
<fpage>35</fpage>&#x2013;<lpage>42</lpage>.
<pub-id pub-id-type="pmid">25248952</pub-id></mixed-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Pierson</surname><given-names>TM</given-names></name>
<name><surname>Tart</surname><given-names>G</given-names></name>
<name><surname>Adams</surname><given-names>D</given-names></name>
<name><surname>Toro</surname><given-names>C</given-names></name>
<name><surname>Golas</surname><given-names>G</given-names></name>
<name><surname>Tifft</surname><given-names>C</given-names></name>
<name><surname>Gahl</surname><given-names>W</given-names></name>
<article-title>Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man.</article-title>
<source>Neuromuscul Disord</source>.
<year>2011</year>;
<volume>21</volume>:
<fpage>353</fpage>&#x2013;<lpage>355</lpage>.
<pub-id pub-id-type="pmid">21353777</pub-id></mixed-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Hamilton</surname><given-names>MJ</given-names></name>
<name><surname>Longman</surname><given-names>C</given-names></name>
<name><surname>O&#x2019;Hara</surname><given-names>A</given-names></name>
<name><surname>Kirkpatrick</surname><given-names>M</given-names></name>
<name><surname>McWilliam</surname><given-names>R</given-names></name>
<article-title>Growing up with spinal muscular atrophy with respiratory distress (SMARD1).</article-title>
<source>Neuromuscul Disord</source>.
<year>2015</year>;
<volume>25</volume>:
<fpage>169</fpage>&#x2013;<lpage>171</lpage>.
<pub-id pub-id-type="pmid">25454169</pub-id></mixed-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Kaindl</surname><given-names>AM</given-names></name>
<name><surname>Guenther</surname><given-names>UP</given-names></name>
<name><surname>Rudnik-Sch&#xF6;neborn</surname><given-names>S</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<name><surname>Zerres</surname><given-names>K</given-names></name>
<name><surname>Gressens</surname><given-names>P</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>Hubner</surname><given-names>C</given-names></name>
<name><surname>von Au</surname><given-names>K</given-names></name>
<article-title>[Distal spinal-muscular atrophy 1 (DSMA1 or SMARD1)].</article-title>
<source>Arch Pediatr</source>.
<year>2008</year>;
<volume>15</volume>:
<fpage>1568</fpage>&#x2013;<lpage>1572</lpage>.
<pub-id pub-id-type="pmid">18804971</pub-id></mixed-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>van der Pol</surname><given-names>WL</given-names></name>
<name><surname>Talim</surname><given-names>B</given-names></name>
<name><surname>Pitt</surname><given-names>M</given-names></name>
<name><surname>von Au</surname><given-names>K</given-names></name>
<article-title>190 th ENMC international workshop: Spinal muscular atrophy with respiratory distress/distal spinal muscular atrophy type 1: 11-13 May 2012, Naarden, The Netherlands.</article-title>
<source>Neuromuscul Disord</source>.
<year>2013</year>;
<volume>23</volume>:
<fpage>602</fpage>&#x2013;<lpage>609</lpage>.
<pub-id pub-id-type="pmid">23726377</pub-id></mixed-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Simone</surname><given-names>C</given-names></name>
<name><surname>Nizzardo</surname><given-names>M</given-names></name>
<name><surname>Rizzo</surname><given-names>F</given-names></name>
<name><surname>Ruggieri</surname><given-names>M</given-names></name>
<name><surname>Riboldi</surname><given-names>G</given-names></name>
<name><surname>Salani</surname><given-names>S</given-names></name>
<name><surname>Bucchia</surname><given-names>M</given-names></name>
<name><surname>Bresolin</surname><given-names>N</given-names></name>
<name><surname>Comi</surname><given-names>GP</given-names></name>
<name><surname>Corti</surname><given-names>S</given-names></name>
<article-title>iPSC-Derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1.</article-title>
<source>Stem Cell Rep</source>.
<year>2014</year>;
<volume>3</volume>:
<fpage>297</fpage>&#x2013;<lpage>311</lpage>.
</mixed-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Rudnik-Sch&#xF6;neborn</surname><given-names>S</given-names></name>
<name><surname>Stolz</surname><given-names>P</given-names></name>
<name><surname>Varon</surname><given-names>R</given-names></name>
<name><surname>Grohmann</surname><given-names>K</given-names></name>
<name><surname>Sch&#xE4;chtele</surname><given-names>M</given-names></name>
<name><surname>Ketelsen</surname><given-names>UP</given-names></name>
<name><surname>Stavrou</surname><given-names>D</given-names></name>
<name><surname>Kurz</surname><given-names>H</given-names></name>
<name><surname>H&#xFC;bner</surname><given-names>C</given-names></name>
<name><surname>Zerres</surname><given-names>K</given-names></name>
<article-title>Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).</article-title>
<source>Neuropediatrics</source>.
<year>2004</year>;
<volume>35</volume>:
<fpage>174</fpage>&#x2013;<lpage>182</lpage>.
<pub-id pub-id-type="pmid">15248100</pub-id></mixed-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Mohan</surname><given-names>U</given-names></name>
<name><surname>Misra</surname><given-names>VP</given-names></name>
<name><surname>Britto</surname><given-names>J</given-names></name>
<name><surname>Muntoni</surname><given-names>F</given-names></name>
<name><surname>King</surname><given-names>RH</given-names></name>
<name><surname>Thomas</surname><given-names>PK</given-names></name>
<article-title>Inherited early onset severe axonal polyneuropathy with respiratory failure and autonomic involvement.</article-title>
<source>Neuromuscul Disord</source>.
<year>2001</year>;
<volume>11</volume>:
<fpage>395</fpage>&#x2013;<lpage>399</lpage>.
<pub-id pub-id-type="pmid">11369191</pub-id></mixed-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Simonati</surname><given-names>A</given-names></name>
<name><surname>Fabrizi</surname><given-names>GM</given-names></name>
<name><surname>Pasquinelli</surname><given-names>A</given-names></name>
<name><surname>Taioli</surname><given-names>F</given-names></name>
<name><surname>Cavallaro</surname><given-names>T</given-names></name>
<name><surname>Morbin</surname><given-names>M</given-names></name>
<name><surname>Marcon</surname><given-names>G</given-names></name>
<name><surname>Papini</surname><given-names>M</given-names></name>
<name><surname>Rizzuto</surname><given-names>N</given-names></name>
<article-title>Congenital hypomyelination neuropathy with Ser72Leu substitution in PMP22.</article-title>
<source>Neuromuscul Disord</source>.
<year>1999</year>;
<volume>9</volume>:
<fpage>257</fpage>&#x2013;<lpage>261</lpage>.
<pub-id pub-id-type="pmid">10399754</pub-id></mixed-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Warner</surname><given-names>LE</given-names></name>
<name><surname>Mancias</surname><given-names>P</given-names></name>
<name><surname>Butler</surname><given-names>IJ</given-names></name>
<name><surname>McDonald</surname><given-names>CM</given-names></name>
<name><surname>Keppen</surname><given-names>L</given-names></name>
<name><surname>Koob</surname><given-names>KG</given-names></name>
<name><surname>Lupski</surname><given-names>JR</given-names></name>
<article-title>Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies.</article-title>
<source>Nat Genet</source>.
<year>1998</year>;
<volume>18</volume>:
<fpage>382</fpage>&#x2013;<lpage>384</lpage>.
<pub-id pub-id-type="pmid">9537424</pub-id></mixed-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Mandich</surname><given-names>P</given-names></name>
<name><surname>Mancardi</surname><given-names>GL</given-names></name>
<name><surname>Varese</surname><given-names>A</given-names></name>
<name><surname>Soriani</surname><given-names>S</given-names></name>
<name><surname>Di Maria</surname><given-names>E</given-names></name>
<name><surname>Bellone</surname><given-names>E</given-names></name>
<name><surname>Bado</surname><given-names>M</given-names></name>
<name><surname>Gross</surname><given-names>L</given-names></name>
<name><surname>Windebank</surname><given-names>AJ</given-names></name>
<name><surname>Ajmar</surname><given-names>F</given-names></name>
<name><surname>Schenone</surname><given-names>A</given-names></name>
<article-title>Congenital hypomyelination due to myelin protein zero Q215X mutation.</article-title>
<source>Ann Neurol</source>.
<year>1999</year>;
<volume>45</volume>:
<fpage>676</fpage>&#x2013;<lpage>678</lpage>.
<pub-id pub-id-type="pmid">10319895</pub-id></mixed-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Bove</surname><given-names>KE</given-names></name>
<name><surname>Iannaccone</surname><given-names>ST</given-names></name>
<article-title>Atypical infantile spinomuscular atrophy presenting as acute diaphragmatic paralysis.</article-title>
<source>Pediatr Pathol</source>.
<year>1988</year>;
<volume>8</volume>:
<fpage>95</fpage>&#x2013;<lpage>107</lpage>.
<pub-id pub-id-type="pmid">3399458</pub-id></mixed-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Butterfield</surname><given-names>RJ</given-names></name>
<name><surname>Stevenson</surname><given-names>TJ</given-names></name>
<name><surname>Xing</surname><given-names>L</given-names></name>
<name><surname>Newcomb</surname><given-names>TM</given-names></name>
<name><surname>Nelson</surname><given-names>B</given-names></name>
<name><surname>Zeng</surname><given-names>W</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Lu</surname><given-names>HM</given-names></name>
<name><surname>Lu</surname><given-names>H</given-names></name>
<name><surname>Farwell Gonzalez</surname><given-names>KD</given-names></name>
<name><surname>Wei</surname><given-names>JP</given-names></name>
<name><surname>Chao</surname><given-names>EC</given-names></name>
<name><surname>Prior</surname><given-names>TW</given-names></name>
<name><surname>Snyder</surname><given-names>PJ</given-names></name>
<name><surname>Bonkowsky</surname><given-names>JL</given-names></name>
<name><surname>Swoboda</surname><given-names>KJ</given-names></name>
<article-title>Congenital lethal motor neuron disease with a novel defect in ribosome biogenesis.</article-title>
<source>Neurology</source>.
<year>2014</year>;
<volume>82</volume>:
<fpage>1322</fpage>&#x2013;<lpage>1330</lpage>.
<pub-id pub-id-type="pmid">24647030</pub-id></mixed-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Rudnik-Sch&#xF6;neborn</surname><given-names>S</given-names></name>
<name><surname>Goebel</surname><given-names>HH</given-names></name>
<name><surname>Schlote</surname><given-names>W</given-names></name>
<name><surname>Molaian</surname><given-names>S</given-names></name>
<name><surname>Omran</surname><given-names>H</given-names></name>
<name><surname>Ketelsen</surname><given-names>U</given-names></name>
<name><surname>Korinthenberg</surname><given-names>R</given-names></name>
<name><surname>Wenzel</surname><given-names>D</given-names></name>
<name><surname>Lauffer</surname><given-names>H</given-names></name>
<name><surname>Kreiss-Nachtsheim</surname><given-names>M</given-names></name>
<name><surname>Wirth</surname><given-names>B</given-names></name>
<name><surname>Zerres</surname><given-names>K</given-names></name>
<article-title>Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy.</article-title>
<source>Neurology</source>.
<year>2003</year>;
<volume>60</volume>:
<fpage>983</fpage>&#x2013;<lpage>987</lpage>.
<pub-id pub-id-type="pmid">12654964</pub-id></mixed-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <mixed-citation publication-type="book" publication-format="undefined">
<name><surname>Harper</surname><given-names>PS</given-names></name>
<name><surname>Monckton</surname><given-names>DG</given-names></name>
<chapter-title>Myotonic dystrophy</chapter-title> In: <name><surname>Engel</surname><given-names>AG</given-names></name>, <name><surname>Franzini-Amstrong</surname></name> (eds). <source>Myology</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>
<year>2004</year> p. <fpage>1039</fpage>-<lpage>1076</lpage>.
</mixed-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Guenther</surname><given-names>UP</given-names></name>
<name><surname>Handoko</surname><given-names>L</given-names></name>
<name><surname>Laggerbauer</surname><given-names>B</given-names></name>
<name><surname>Jablonka</surname><given-names>S</given-names></name>
<name><surname>Chari</surname><given-names>A</given-names></name>
<name><surname>Alzheimer</surname><given-names>M</given-names></name>
<name><surname>Ohmer</surname><given-names>J</given-names></name>
<name><surname>Pl&#xF6;ttner</surname><given-names>O</given-names></name>
<name><surname>Gehring</surname><given-names>N</given-names></name>
<name><surname>Sickmann</surname><given-names>A</given-names></name>
<name><surname>von Au</surname><given-names>K</given-names></name>
<name><surname>Schuelke</surname><given-names>M</given-names></name>
<name><surname>Fischer</surname><given-names>U</given-names></name>
<article-title>IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1).</article-title>
<source>Hum Mol Genet</source>.
<year>2009</year>;
<volume>18</volume>:
<fpage>1288</fpage>&#x2013;<lpage>1300</lpage>.
<pub-id pub-id-type="pmid">19158098</pub-id></mixed-citation>
      </ref>
      <ref id="b29">
        <label>29</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Bertini</surname><given-names>E</given-names></name>
<name><surname>Houlden</surname><given-names>H</given-names></name>
<article-title>Defects of RNA metabolism in the pathogenesis of spinal muscular atrophy.</article-title>
<source>Neurology</source>.
<year>2014</year>;
<volume>82</volume>:
<fpage>1298</fpage>&#x2013;<lpage>1299</lpage>.
<pub-id pub-id-type="pmid">24647031</pub-id></mixed-citation>
      </ref>
      <ref id="b30">
        <label>30</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Sangiuolo</surname><given-names>F</given-names></name>
<name><surname>Filareto</surname><given-names>A</given-names></name>
<name><surname>Giardina</surname><given-names>E</given-names></name>
<name><surname>Nardone</surname><given-names>AM</given-names></name>
<name><surname>Pilu</surname><given-names>G</given-names></name>
<name><surname>Pietropolli</surname><given-names>A</given-names></name>
<name><surname>Bertini</surname><given-names>E</given-names></name>
<name><surname>Novelli</surname><given-names>G</given-names></name>
<article-title>Prenatal diagnosis of spinal muscular atrophy with respiratory distress (SMARD1) in a twin pregnancy.</article-title>
<source>Prenat Diagn</source>.
<year>2004</year>;
<volume>24</volume>:
<fpage>839</fpage>&#x2013;<lpage>841</lpage>.
<pub-id pub-id-type="pmid">15503272</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
